AIMS/HYPOTHESIS: We hypothesised that the blunted baroreflex sensitivity (BRS) typical of type 1 diabetes is caused by a higher degree of tissue hypoxia in diabetes, and tested whether oxygen increased BRS and ventilation less, equally or more than in healthy control participants (the latter suggesting higher tissue hypoxia). In addition, we also considered the possible interference between oxygen and breathing pattern. METHODS: In 96 participants with type 1 diabetes and 40 age-matched healthy controls, we measured BRS (average of six different standard methods), oxygen saturation, end-tidal carbon dioxide and ventilation changes during spontaneous and controlled breathing at 15 and six breaths/min, in normoxia and during 5 l/min oxygen administration. RESULTS: BRS was blunted and blood pressure higher in diabetic participants during spontaneous breathing (p < 0.05). BRS increased with oxygen during spontaneous breathing in diabetic (p < 0.001) but not in control participants, and with oxygen the difference in BRS was no longer significant. Slow breathing in normoxia restored BRS to a similar extent to giving oxygen. Oxygen increased systolic and diastolic blood pressure, RR interval, heart rate variability, minute ventilation and tidal volume to a greater extent in diabetic patients than in controls, and decreased carbon dioxide similarly to controls. CONCLUSIONS/ INTERPRETATION: The increased response to hyperoxia suggests a pre-existing condition of tissue hypoxia that functionally restrains parasympathetic activity in patients with type 1 diabetes. Autonomic abnormalities can be partially and temporarily reversed by functional manoeuvres such as slow breathing or oxygen administration through enhancement of parasympathetic activity and/or correction of tissue hypoxia.
AIMS/HYPOTHESIS: We hypothesised that the blunted baroreflex sensitivity (BRS) typical of type 1 diabetes is caused by a higher degree of tissue hypoxia in diabetes, and tested whether oxygen increased BRS and ventilation less, equally or more than in healthy control participants (the latter suggesting higher tissue hypoxia). In addition, we also considered the possible interference between oxygen and breathing pattern. METHODS: In 96 participants with type 1 diabetes and 40 age-matched healthy controls, we measured BRS (average of six different standard methods), oxygen saturation, end-tidal carbon dioxide and ventilation changes during spontaneous and controlled breathing at 15 and six breaths/min, in normoxia and during 5 l/min oxygen administration. RESULTS: BRS was blunted and blood pressure higher in diabeticparticipants during spontaneous breathing (p < 0.05). BRS increased with oxygen during spontaneous breathing in diabetic (p < 0.001) but not in control participants, and with oxygen the difference in BRS was no longer significant. Slow breathing in normoxia restored BRS to a similar extent to giving oxygen. Oxygen increased systolic and diastolic blood pressure, RR interval, heart rate variability, minute ventilation and tidal volume to a greater extent in diabeticpatients than in controls, and decreased carbon dioxide similarly to controls. CONCLUSIONS/ INTERPRETATION: The increased response to hyperoxia suggests a pre-existing condition of tissue hypoxia that functionally restrains parasympathetic activity in patients with type 1 diabetes. Autonomic abnormalities can be partially and temporarily reversed by functional manoeuvres such as slow breathing or oxygen administration through enhancement of parasympathetic activity and/or correction of tissue hypoxia.
Authors: Dominique Laude; Jean-Luc Elghozi; Arlette Girard; Elisabeth Bellard; Malika Bouhaddi; Paolo Castiglioni; Catherine Cerutti; Andrei Cividjian; Marco Di Rienzo; Jacques-Olivier Fortrat; Ben Janssen; John M Karemaker; Georges Lefthériotis; Gianfranco Parati; Pontus B Persson; Alberto Porta; Luc Quintin; Jacques Regnard; Heinz Rüdiger; Harald M Stauss Journal: Am J Physiol Regul Integr Comp Physiol Date: 2003-09-18 Impact factor: 3.619
Authors: L Bernardi; C Passino; G Spadacini; A Calciati; R Robergs; R Greene; E Martignoni; I Anand; O Appenzeller Journal: Clin Sci (Lond) Date: 1998-11 Impact factor: 6.124
Authors: A Frattola; G Parati; P Gamba; F Paleari; G Mauri; M Di Rienzo; P Castiglioni; G Mancia Journal: Diabetologia Date: 1997-12 Impact factor: 10.122
Authors: Elisabetta De Tommasi; Massimo Iacoviello; Roberta Romito; Claudio Ceconi; Pietro Guida; Francesco Massari; Gloria Francolini; Federico Bertocchi; Roberto Ferrari; Paolo Rizzon; Maria Vittoria Pitzalis Journal: Am Heart J Date: 2003-11 Impact factor: 4.749
Authors: Jacqueline K Limberg; Simmi Dube; Myrthe Kuijpers; Kathryn E Farni; Ananda Basu; Robert A Rizza; Timothy B Curry; Rita Basu; Michael J Joyner Journal: Clin Auton Res Date: 2015-07-04 Impact factor: 4.435
Authors: Jens Christian Laursen; Niels Søndergaard-Heinrich; Joana Mendes Lopes de Melo; Bryan Haddock; Ida Kirstine Bull Rasmussen; Farzaneh Safavimanesh; Christian Stevns Hansen; Joachim Størling; Henrik Bo Wiberg Larsson; Per-Henrik Groop; Marie Frimodt-Møller; Ulrik Bjørn Andersen; Peter Rossing Journal: EClinicalMedicine Date: 2021-06-28
Authors: Tobias Duennwald; Luciano Bernardi; Daniel Gordin; Anna Sandelin; Anna Syreeni; Christopher Fogarty; Janne P Kytö; Hannes Gatterer; Markku Lehto; Sohvi Hörkkö; Carol Forsblom; Martin Burtscher; Per-Henrik Groop Journal: Diabetes Date: 2013-06-03 Impact factor: 9.461
Authors: Kenneth N Grisé; T Dylan Olver; Matthew W McDonald; Adwitia Dey; Mao Jiang; James C Lacefield; J Kevin Shoemaker; Earl G Noble; C W James Melling Journal: J Diabetes Res Date: 2016-01-18 Impact factor: 4.011
Authors: Sławomir Kujawski; Joanna Słomko; Karl J Morten; Modra Murovska; Katarzyna Buszko; Julia L Newton; Paweł Zalewski Journal: Medicina (Kaunas) Date: 2020-04-10 Impact factor: 2.430